Home The Word Brain My Amedeo FAQ Privacy About


Amedeo Chinese

For Medical Students & Physicians

A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever.

Download the free PDF: Amedeo Chinese PDF

  Ovarian Neoplasms

  Free Subscription


01.06.2026

1 Am J Clin Pathol
1 BMC Cancer
1 Cancer Lett
1 Cancer Res
1 Clin Cancer Res
1 Mol Ther Oncol


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Clin Pathol

  1. MUKHOPADHYAY S, Montgomery J, Chughtai A, Eltz Soares L, et al
    Radiation injury to the lung caused by yttrium-90 resin microspheres (SIR-Spheres) diagnosed by transbronchial lung biopsy.
    Am J Clin Pathol. 2026;165:aqag056.
    PubMed         Abstract available


    BMC Cancer

  2. RODMAN EPB, Bhagwate A, Smith HM, Emch MJ, et al
    STAT1 and STAT3 signaling in ovarian cancer: prognostic biomarkers and therapeutic targets.
    BMC Cancer. 2026 May 25. doi: 10.1186/s12885-026-16226.
    PubMed         Abstract available


    Cancer Lett

  3. WANG H, Wang X, Zhang W, Hu S, et al
    Arginine restriction exploits DNMT3B-ASS1-driven arginine auxotrophy and mTORC1-suppressed autophagy to overcome niraparib resistance in ovarian cancer.
    Cancer Lett. 2026;654:218582.
    PubMed         Abstract available


    Cancer Res

  4. ZHANG Y, Yang B, Hou X, Ming W, et al
    Spatially Resolved Molecular Subtyping Uncovers Tumor Progression and Immune Evasion Mechanisms in High-Grade Serous Ovarian Cancer.
    Cancer Res. 2026 May 27. doi: 10.1158/0008-5472.CAN-25-4749.
    PubMed         Abstract available


    Clin Cancer Res

  5. GUO J, Wu Y, Huang W, Ai G, et al
    PiggyBac-engineered membrane-bound IL-7 TILs combined with anti-PD-1 antibody demonstrates efficacy in recurrent ovarian cancer: a first-in-human phase 1 trial.
    Clin Cancer Res. 2026 May 26. doi: 10.1158/1078-0432.CCR-25-4130.
    PubMed         Abstract available


    Mol Ther Oncol

  6. MOONEY R, Ngai G, Kaur G, Kang EY, et al
    Neural stem cell delivery of oncolytic CRAd-S-pk7 immunotherapy for stage 3 ovarian cancer: Dose-regimen studies.
    Mol Ther Oncol. 2026;34:201219.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ovarian Neoplasms is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum